Notal Vision is committed to transforming the detection and diagnosis of ocular diseases. As new therapies come to market and the population ages, the costs of delivering healthcare continue to rise. Extending ophthalmic and systemic disease management beyond the clinic can positively impact the economics of healthcare as well as the medical benefits for patients.
We seek to understand the unmet medical needs associated with ophthalmic diseases and their treatments. We want to design home monitoring solutions that are easy to use and improve doctors’ ability to provide optimal vision outcomes for their patients.
Partnering with eye care specialists to validate our understanding of the unmet need and the complexities associated with delivering eye care today, we continually challenge ourselves to provide value-enhancing approaches for patients and their families, physicians, and payers.
|Candidate||Overview||Disease State||Stage of Development|
|Home-Based Optical Coherence Tomography (OCT)||Home-based OCT for patients with retinal vascular diseases||Retinal diseases with fluid accumulation||Clinical|
|NOA OCT Analyzer (wAMD)||Automated detection of disease activity with proprietary algorithm||Wet AMD||Clinical|
|NOA OCT Analyzer (DME)||Automated detection of disease activity with proprietary algorithm||Diabetic Macular Edema||Clinical|
|NOA OCT Analyzer (dAMD)||Automated detection of disease activity with proprietary algorithm||Dry AMD||Clinical|